Welcome to Bloomberg Law’s Wake Up Call, a daily rundown of the top news for lawyers, law firms, and in-house counsel.

Norton Rose Fulbright hired Anne Johnson as a partner and US head of appellate in the Dallas office, the firm announced Tuesday.

The Justice Department is urging the Supreme Court to limit birthright citizenship for the first time since the justices famously rejected the government’s attempt to deny citizenship to a man born in the US to Chinese immigrants.

The NFL should fight Florida’s recent push to invalidate the Rooney Rule for allegedly violating the state’s Civil Rights Act.

Junior lawyers looking to move up in their careers should use a few strategies to set themselves apart: Help solve others’ problems, differentiate themselves, and be social while staying professional.

A close look at the legality of birth tourism sheds light on the landmark birthright citizenship case before the US Supreme Court.

Participants in the Johns Hopkins Health System Corp.'s retirement benefits plan are accusing the company and an administrative committee of breaching their fiduciary duties, arguing their actions caused plan assets to plummet by about $300 million.

Partisan differences in judicial review of National Labor Relations Board decisions are poised to expand as the Trump administration adds even more judges to courts that have stepped up their scrutiny of agency actions.

Benefits attorneys and retirement plan sponsors are rushing to unpack a new proposal from the Department of Labor that outlines a legal safe harbor for fiduciaries to offer more alternative investment assets in 401(k)s.

Union Pacific Corp.'s CEO sees his proposed combination with Norfolk Southern Corp. as the logical capstone of almost five decades in railroading — and what Abraham Lincoln would have wanted.

The NFL should fight Florida’s recent push to invalidate the Rooney Rule for allegedly violating the state’s Civil Rights Act.

Junior lawyers looking to move up in their careers should use a few strategies to set themselves apart: Help solve others’ problems, differentiate themselves, and be social while staying professional.

Deloitte has called on the Irish government to launch a number of new tax credits as part of a push to attract fresh foreign investment to the country.

South Africa cut fuel taxes to cushion a surge in oil prices driven by the war in Iran, with gasoline and diesel costs set for their steepest increase in almost two decades.

The US government’s largest affordable housing program was supposed to be supercharged by President Donald Trump’s signature tax law. So far, that jolt hasn’t arrived.

Japan’s companies paid a record amount in taxes last fiscal year, finally exceeding the amount they paid when the economy was in the last throes of the 1989 bubble economy.

Accounting professionals and business groups are calling for stricter controls on the governing board of Australia’s proposed accounting, audit and assurance standards body.

Some of the country’s wealthiest corporations are calculating they owe far less to the Internal Revenue Service as a result of President Donald Trump’s overhauled tax code, underscoring how a law billed as a middle‑class cut also turned out to be a big win for Corporate America.

First JPMorgan Chase & Co. said it would tackle economic security. Next up: the American Dream.

Unilever Plc agreed to combine its food business with spice maker McCormick & Co. in a $44.8 billion deal that will create a global seasonings, sauces and condiments company.

Tenex.ai, an artificial intelligence cybersecurity startup, has raised $250 million in funding at a more than $1 billion valuation, the latest sign of investor demand for companies that use AI to combat cyber attacks.

Iran hit a fully laden Kuwaiti oil tanker off the coast of Dubai during a fresh wave of attacks around the Persian Gulf, a sign it’s willing to escalate strikes on energy assets as the war drags on.

The push to protect children from social media’s harms is gaining momentum globally and beginning to reach Big Tech’s home turf in the US.

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments in immunology and rare diseases in one of the company’s largest-ever acquisitions.